Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Venus Remedies Ltd (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013463
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, lyophilized injections, pre-filled syringes, cephalosphorins, and others. Venus offers research services such as analytical research and development, cellular and molecular biology, microbiology, formulation development, pre-clinical and toxicological research, drug regulatory affairs, and intellectual property consultation. The company operates through its injectable manufacturing units located in Panchkula and Baddi, India; and Werne, Germany. Venus is headquartered in Panchkula, Haryana, India.

Venus Remedies Ltd (VENUSREM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 10
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 11
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 12
Licensing Agreements 13
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 13
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 16
Equity Offering 17
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 17
Venus Remedies Completes Private Placement Of Shares For US$3.7 Million Upon Exercise Of Warrants 18
Venus Remedies Ltd – Key Competitors 19
Venus Remedies Ltd – Key Employees 20
Venus Remedies Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
May 30, 2017: Venus Remedies Reports Total Income Of INR4 Billion In Fiscal 2017 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Venus Remedies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 10
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 11
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 12
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 13
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 16
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 17
Venus Remedies Completes Private Placement Of Shares For US$3.7 Million Upon Exercise Of Warrants 18
Venus Remedies Ltd, Key Competitors 19
Venus Remedies Ltd, Key Employees 20
Venus Remedies Ltd, Other Locations 21
Venus Remedies Ltd, Subsidiaries 21

★海外企業調査レポート[Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Telephonics Corporation:企業の戦略的SWOT分析
    Telephonics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Oge Energy Corp:企業の戦略・SWOT・財務分析
    Oge Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Oge Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Advanced Info Service PLC (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service PLC (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • American Shared Hospital Services (AMS)-医療機器分野:企業M&A・提携分析
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • Direct Conversion AB:企業の戦略的SWOT分析
    Direct Conversion AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務分析
    Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Seadrill Limited (SDRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Seadrill Limited (Seadrill) is an offshore drilling contractor. The company provides contract drilling, well services and engineering services to offshore exploration and production companies. Its fleet includes drillships, jack-up rigs, semi-submersibles, and tender rigs for operations in s …
  • STMicroelectronics N.V. (STM)-エネルギー分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Electra Private Equity plc (ELTA):企業の財務・戦略的SWOT分析
    Electra Private Equity plc (ELTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sports Direct International Plc:企業のM&A・事業提携・投資動向
    Sports Direct International Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sports Direct International Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • United Insurance Holdings Corp.:企業の戦略・SWOT・財務情報
    United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Banco Angolano de Investimentos, SA:企業の戦略・SWOT・財務情報
    Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report Summary Banco Angolano de Investimentos, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Dexcel PT Israel Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planing and adult p …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • General Electric Co (GE):電力:M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • Ecopetrol SA (ECOPETROL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecopetrol SA (Ecopetrol) is a vertically integrated oil and gas company that carries out exploration, development and production of oil and gas. It is also involved in refining of crude oil to produce petroleum products, besides transportation services. Ecopetrol owns and operates refineries …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆